{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:25:15Z","timestamp":1792725915796,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.tmrv.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:16:19Z","timestamp":1561058179000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Lilian Antwi","family":"Boateng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain Mayindu","family":"Ngoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imelda","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Schonewille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2019.06.003_bb0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"Piel","year":"2010","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0010","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-3148.2009.00943.x","article-title":"Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy?","volume":"20","author":"Agasa","year":"2010","journal-title":"Transfus Med"},{"issue":"9","key":"10.1016\/j.tmrv.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1464-5491.2012.03620.x","article-title":"Would sickle cell trait influence the metabolic control in sub-Saharan individuals with type 2 diabetes?","volume":"29","author":"Ama","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.meegid.2014.04.003","article-title":"Prevalence of the sickle cell trait in Gabon: a nationwide study","volume":"25","author":"Delicat-Loembet","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0348","article-title":"Time to invest in sickle cell anemia as a global health priority","volume":"137","author":"McGann","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0035","doi-asserted-by":"crossref","unstructured":"Wang WC, Morales KH, Scher CD, Styles L, Olivieri N, Adams R, et al. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. J Pediatr 2005; 147(2):244\u20137. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2005.02.030","DOI":"10.1016\/j.jpeds.2005.02.030"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0040","doi-asserted-by":"crossref","unstructured":"Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 2006; 108(3):847\u201352. doi: https:\/\/doi.org\/10.1182\/blood","DOI":"10.1182\/blood-2005-10-009506"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOP.0b013e328321882e","article-title":"Current issues in blood transfusion for sickle cell disease","volume":"21","author":"Wahl","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0050","unstructured":"WHO 2017 blood safety and availability https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability accessed on 16th December, 2018"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tmrv.2011.07.006","article-title":"Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges","volume":"26","author":"Bloch","year":"2012","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/trf.14949","article-title":"Blood transfusion safety in sub-Saharan Africa: a literature review of changes and challenges in the 21st century","volume":"59","author":"Weimer","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tmrv.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1196\/annals.1345.072","article-title":"Allosensitization in patients receiving multiple blood transfusions","volume":"1054","author":"Sakhalkar","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.tmrv.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.tmrv.2019.06.003_bb0085","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0090","doi-asserted-by":"crossref","unstructured":"Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res 2005, 38(5):675\u201382. doi.org\/10.1590\/S0100-879X2005000500004","DOI":"10.1590\/S0100-879X2005000500004"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/trf.13037","article-title":"Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease","volume":"55","author":"Karafin","year":"2015","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.tmrv.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.24051","article-title":"Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease","volume":"90","author":"Desai","year":"2015","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.tmrv.2019.06.003_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/iji.12334","article-title":"318C\/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients","volume":"44","author":"Oliveira","year":"2017","journal-title":"Int J Immunogenet"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/trf.13920","article-title":"Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms","volume":"57","author":"Sippert","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0120","doi-asserted-by":"crossref","unstructured":"Garratty, G. (2004) Autoantibodies induced by blood transfusion. Transfusion 2004; 44(1): 59.","DOI":"10.1111\/j.0041-1132.2004.00658.x"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhaemolysis syndrome in sickle cell disease","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"10.1016\/j.tmrv.2019.06.003_bb0130","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.5858\/arpa.2017-0251-RS","article-title":"Hyperhaemolysis syndrome in patients with sickle cell disease","volume":"142","author":"Banks","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.tmrv.2019.06.003_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1537-2995.1997.37497265334.x","article-title":"Severe reactions associated with transfusion of patients with sickle cell disease","volume":"37","author":"Garratty","year":"1997","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.tmrv.2019.06.003_bb0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3324\/haematol.2010.038307","article-title":"Piet al. Delayed hemolytic transfusion reaction in children with sickle cell disease","volume":"96","author":"de Montalembert","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0150","first-page":"14","article-title":"Hyperhemolysis associated with red-cell transfusion in sickle-cell disease","volume":"33S","author":"Friedman","year":"1993","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1537-2995.2002.00126.x","article-title":"Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications","volume":"42","author":"Castro","year":"2002","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.tmrv.2019.06.003_bb0160","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/trf.13696","article-title":"Delaney, et al. Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study","volume":"56","author":"Yazer","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","author":"Tormey","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tmrv.2019.06.003_bb0170","first-page":"205","article-title":"The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown","volume":"11","author":"Hlela","year":"2009","journal-title":"AIDS Rev"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0175","unstructured":"Schwarzer G. Meta: meta-analysis with R. Available: http:\/\/cran.r-project.org\/web\/packages\/meta\/"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0180","doi-asserted-by":"crossref","unstructured":"Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res1993; 2:121\u201345","DOI":"10.1177\/096228029300200202"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.tmrv.2019.06.003_bb0190","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","article-title":"In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias","volume":"67","author":"Hunter","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0195","first-page":"64","article-title":"Alloimmunisation anti \u00b4erythrocytaire post transfusionnelle chez les dr'epanocytaires au CHU de Cocody Abidjan","volume":"9","author":"Akre","year":"2008","journal-title":"Int J Pharma Bio Sci"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0200","doi-asserted-by":"crossref","unstructured":"Batina Agasa S, Dupont E, Kayembe T, Molima P, Malengela R. Kabemba S, et al. Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010; 17(4):254\u20139.","DOI":"10.1016\/j.tracli.2010.09.002"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0205","doi-asserted-by":"crossref","unstructured":"Boma Muteb P, Kaliula Mamba JFJ, Muhai Pfutila P, BiloV, Panda Mulefu JD, Diallo DA. Effectiveness, safety, and cost of partial exchange transfusions in patients with sickle-cell anemia at a sickle cell disease center in sub-Saharan Africa. Med Sante Trop 2017; 1:27(4):387\u201391. doi: https:\/\/doi.org\/10.1684\/mst.2017.0719. doi: https:\/\/doi.org\/10.1684\/mst.2017.0719","DOI":"10.1684\/mst.2017.0719"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0210","first-page":"297","article-title":"Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi","volume":"4","author":"Mangare","year":"2015","journal-title":"Kenya Afr J Lab Med"},{"issue":"4","key":"10.1016\/j.tmrv.2019.06.003_bb0215","first-page":"61","article-title":"Red blood cell alloimmunization among Sudanese homozygous sickle cell disease patients","volume":"3","author":"Abbas","year":"2013","journal-title":"Am J Med Med Sci"},{"issue":"12","key":"10.1016\/j.tmrv.2019.06.003_bb0220","first-page":"137","article-title":"Red cell alloimmunization in blood transfusion dependent patients with sickle cell disease in El-Obied city","volume":"14","author":"Eldour","year":"2016","journal-title":"Sudan IOSR-JDMS"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0225","first-page":"775","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Tanzania","volume":"11","author":"Meda","year":"2014","journal-title":"East Afr J Public Health"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2009.02435.x","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Uganda","volume":"50","author":"Natukunda","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0235","doi-asserted-by":"crossref","unstructured":"Sekongo YMV, Kouacou AP, Kouamenan GS, Kassogue KL, N'Guessan P, Danho NC, et al. Anti-erythrocyte allo-immunization to sickle cell disease patients followed in transfusion therapy unit of the National Blood Transfusion Center of Abidjan C\u00f4te D'Ivoire'. Int J Immunol 2017; 5(1):1\u20134. doi: 10.11648\/j.iji.20170501.11","DOI":"10.11648\/j.iji.20170501.11"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0240","first-page":"1","article-title":"Immune status and red cell alloimmunization among SCD patients in C\u00f4te d'Ivoire","volume":"3","author":"Siransy","year":"2018","journal-title":"J Clin Exp Immunol 2018"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0245","doi-asserted-by":"crossref","unstructured":"Boateng, LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille, H. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease. Transfusion doi: 10.1111\/trf.15197 Epub ahead of print","DOI":"10.1111\/trf.15197"},{"issue":"5\/6","key":"10.1016\/j.tmrv.2019.06.003_bb0250","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tracli.2013.04.111","article-title":"S\u00e9curit\u00e9 transfusionnelle et dr\u00e9panocytose \u00e0 Bamako, Mali. S\u00e9ropr\u00e9valence des infections \u00e0 VIH, VHB, VHC et allo-immunisation anti-Rh et Kell chez les dr\u00e9panocytaires","volume":"20","author":"Diarra","year":"2013","journal-title":"Transfus Clin Biol"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0255","first-page":"1","article-title":"Prevalence of red cell alloantibodies in multi-transfused patients with sickle cell anemia in Nigeria","volume":"8","author":"Kuliya-Gwarzo","year":"2005","journal-title":"Africa Sanguin"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0260","doi-asserted-by":"crossref","unstructured":"Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Mohammed N. Pattern and prevalence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria. Biomark Res 2015; 3:26. DOI https:\/\/doi.org\/10.1186\/s40364-015-0050-3. doi: https:\/\/doi.org\/10.1186\/s40364-015-0050-3","DOI":"10.1186\/s40364-015-0050-3"},{"issue":"4","key":"10.1016\/j.tmrv.2019.06.003_bb0265","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/1119-3077.154204","article-title":"Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City","volume":"18","author":"Ugwu","year":"2015","journal-title":"Nigeria Niger J Clin Pract"},{"issue":"10","key":"10.1016\/j.tmrv.2019.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/21755","article-title":"Erythrocyte transfusion and alloimmunization patterns among sickle cell disease patients, Benin City","volume":"11","author":"Adewoyin","year":"2016","journal-title":"Nigeria. Br J Med Med Res"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0275","series-title":"The blood group antigen factsbook","author":"Reid","year":"2012"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.transci.2015.10.017","article-title":"Red blood cell alloimmunization in transfused patients in sub-Saharan Africa: a systematic review and meta-analysis","volume":"54","author":"Ngoma","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0285","doi-asserted-by":"crossref","unstructured":"Fasano RM, Meyer EK. Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev 2019; 33(1):12\u201323. doi: https:\/\/doi.org\/10.1016\/j.tmrv.2018.07.003.","DOI":"10.1016\/j.tmrv.2018.07.003"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0290","article-title":"The erythrocyte alloimmunization in patients with sickle cell anemia: a systematic review","volume":"2018","author":"da Cunha Gomes","year":"2018","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tracli.2011.09.001","article-title":"Relevance of RH variants in transfusion of sickle cell patients","volume":"18","author":"Noizat-Pirenne","year":"2011","journal-title":"Transfus Clin Biol J Soci\u00e9t\u00e9 Fr Transfus Sang"},{"issue":"6","key":"10.1016\/j.tmrv.2019.06.003_bb0300","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tmrv.2019.06.003_bb0305","first-page":"44","article-title":"The frequency of Kell red cell antigens (K, k) among the major Sudanese tribes","volume":"4","author":"Akasha","year":"2012","journal-title":"Recent Res Sci Technol 2012"},{"issue":"2","key":"10.1016\/j.tmrv.2019.06.003_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21307\/immunohematology-2018-011","article-title":"Rh and Kell blood group antigen prevalence in a multi-ethnic cohort in Nigeria: implications for local transfusion service","volume":"34","author":"Adewoyin","year":"2018","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0315","article-title":"Kell blood group antigen in Port Harcourt, Nigeria: a pilot study","volume":"4","author":"Ugboma","year":"2009","journal-title":"Port Harcourt Med J"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000153563","article-title":"Some red cell antigens in the Hausa population of northern Nigeria","volume":"35","author":"Kulkarni","year":"1985","journal-title":"Hum Hered"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0325","first-page":"301","article-title":"Distribution of Kell phenotype among pregnant women in Sokoto","volume":"21","author":"Osaro","year":"2015","journal-title":"North Western Nigeria Pan Afr Med J"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0330","doi-asserted-by":"crossref","unstructured":"Siransy Bogui L, Dembele B, Sekongo Y, Abisse, Konat\u00e9 S, Sombo M. Phenotypic profile of Rh and Kell blood group systems among blood donors in Cote d'Ivoire, West Africa. J Blood Transfus 2014; 1\u20134 https:\/\/doi.org\/10.1155\/2014\/309817","DOI":"10.1155\/2014\/309817"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0335","first-page":"495","article-title":"Low frequency antigens in human blood groups, 3rd edition","author":"Daneils","year":"2013","journal-title":"Wiley-Blackwell"},{"issue":"4","key":"10.1016\/j.tmrv.2019.06.003_bb0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<248::AID-AJH8>3.0.CO;2-Y","article-title":"Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen","volume":"53","author":"Larson","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0345","doi-asserted-by":"crossref","unstructured":"Mattos LCD. Molecular polymorphisms of human blood groups: a universe to unravel. Rev Bras Hematol Hemoter 2011; 33(1):6\u20137. doi: https:\/\/doi.org\/10.5581\/1516-8484.20110005","DOI":"10.5581\/1516-8484.20110005"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0350","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/trf.13704","article-title":"Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence","volume":"56","author":"Stack","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.06.003_bb0355","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/vox.12705","article-title":"Blood transfusion in sub-Saharan Africa: understanding the missing gap and responding to present and future challenges","volume":"113","author":"Barro","year":"2018","journal-title":"Vox Sang"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796319300227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796319300227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:44Z","timestamp":1760138324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796319300227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0887796319300227"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.06.003","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}